logo
episode-header-image
May 2020
18m 25s

COVID-19 Digest: Could Cigarette Smoking...

EMERGENCY MEDICAL MINUTE
About this episode

Host: Elizabeth Esty, MD.

Smoking is known to increase both susceptibility and severity of all manner of colds and pneumonias, so you’d think the world's 1.1 billion smokers would be at risk in this pandemic of what at first seemed to be a just a respiratory virus. 

What’s more, tobacco smoking increases risk for COPD, diabetes and coronary disease, so it may increase risk for more severe COVID indirectly. So it’s remarkable that preliminary evidence suggests that smokers may be less likely to be harmed by COVID than non-smokers. A story that’s gotten a fair amount of attention in the media concerns reports from France that smoking may be protective against COVID. We took a closer look and found that similar reports are coming in from across the globe, including the US. We decided to take some time to look at papers and attempt to explain this relationship. 

Research By: Elizabeth Esty, MD.

Sound Editing By: Nathan Novotny.

References:

[1] Miyara M, Tubach F, Pourcher V, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios. April 2020. doi:10.32388/WPP19W.3

[2] Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032

[3] Chow N, Fleming-Dutra K, Gierke R, et al. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382-386. doi:10.15585/mmwr.mm6913e2

[4] Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. April 2020. doi:10.1001/jama.2020.6775

[5] Berlin I, Thomas D, Le Faou A-L, Cornuz J. COVID-19 and Smoking. Nicotine Tob Res. doi:10.1093/ntr/ntaa059

[6] Farsalinos K, Niaura R, Houezec JL, et al. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicology Reports. doi:10.1016/j.toxrep.2020.04.012

 

Photo Sourced From:

https://www.henryford.com/blog/2020/04/smoking-and-vaping-increase-covid-risks

Up next
Mar 2025
Episode 946: Time to Defibrillation
Contributor: Aaron Lessen, MD Educational Pearls: Quick background info Cardiac arrest is when the heart stops pumping blood for any reason. This is different from a heart attack in which the heart is still working but the muscle itself is starting to die. One cause of cardiac ar ... Show More
2m 30s
Feb 2025
Episode 945: Ketorolac vs. Ibuprofen
Contributor: Ricky Dhaliwal, MD Educational Pearls:  Ketorolac and ibuprofen are NSAIDs with equivalent efficacy for pain in the emergency department Oral ibuprofen provides the same relief as intramuscular ketorolac IM ketorolac is associated with the adverse effect of a painful ... Show More
3m 30s
Feb 2025
Episode 944: Colchicine Overdose
Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin b ... Show More
3m 19s
Recommended Episodes
Dec 2021
Lung disease among e-cigarette users, 2021 AMA Research Challenge finalist
Resident candidate, IMG, and AMA Research Challenge finalist Dr. Naga Ganti discusses her research on the prevalence of lung disease among e-cigarettes users, especially given that more than 2 million US youth use e-cigarettes. Poster: Epidemiology and prevalence of lung disease ... Show More
9m 26s
Nov 2023
ZFA TALK: Das ABC des Rauchstopps
mit Prof. Dr. Daniel Kotz, Suchtforscher (00:57) Rauchverhalten in Deutschland | (04:12) Gesundheitliche Folgen des Rauchens | (06:04) Suchtproblematik | (10:16) Rolle der Hausarztpraxis | (14:15) Aktuelle Leitlinienempfehlungen zur Beratung und pharmakologischen Optionen | (18:3 ... Show More
28m 1s
Feb 2022
La fumée de cigarette peut-elle véhiculer le Covid ?
Depuis les débuts de la pandémie de Covid-19, les scientifiques se posent de nombreuses questions sur le mode de transmission du virus. Ainsi, certains se demandent si la fumée de cigarette ne serait pas de nature à en faciliter la propagation. Un virus transporté plus loin ? Dep ... Show More
1m 52s
Sep 2023
How can I stop smoking?
We all know that the effects of tobacco on the human body are devastating. The World Health Organisation says that it kills more than 8 million people each year, making it one of the biggest public health threats the world has ever seen.It’s hardly surprising when you consider th ... Show More
4m 30s
Sep 2023
330. Guidelines: 2021 ESC Cardiovascular Prevention – Question #33 with Dr. Noreen Nazir
The following question refers to Section 4.5 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Maryam Barkhordarian, answered first by pharmacy resident Dr. Anushka Tandon, and then by expert faculty Dr. Noreen Nazir. Dr. Nazir is Assistant Professor of Clini ... Show More
11m 14s
Apr 2021
Apr 30, 2021 This Week in Cardiology Podcast
COVID-19 and global vaccinations, AF screening, conduction-system pacing, FDA ban on menthol tobacco, and a heartfelt essay are the topics John Mandrola, MD, discusses in this week’s podcast. https://www.medscape.com/twic COVID-19 Indians Rush for COVID-19 Vaccines as Death Toll ... Show More
23m 3s
Apr 2023
S2 Episode 2: When Viral Pandemics Collide: Vaccinating, Boosting and Caring for Patients Diagnosed With HIV During the Time of COVID
Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions. Relevant disclosures can be found with the episode show notes ... Show More
24m 7s